Skip to main content
Premium Trial:

Request an Annual Quote

PerkinElmer Pens Biomarker R&D Alliances With Johns Hopkins, University of Birmingham

NEW YORK (GenomeWeb News) — PerkinElmer today said it will help Johns Hopkins University and the University of Birmingham, UK, establish tools and technologies to discover diagnostic and therapeutic biomarkers in undisclosed indications.
 
PerkinElmer said it will use its BioExpression platform, a carrier protein-based biomarker enrichment technology that is used to find low-abundance disease-related biomarkers.
 
The company said these collaborations “will become a major driver in the rapidly emerging field of proteomics, developing new technologies for clinical research.”
 
Financial details of the deals were not disclosed.

The Scan

Tens of Millions Saved

The Associated Press writes that vaccines against COVID-19 saved an estimated 20 million lives in their first year.

Supersized Bacterium

NPR reports that researchers have found and characterized a bacterium that is visible to the naked eye.

Also Subvariants

Moderna says its bivalent SARS-CoV-2 vaccine leads to a strong immune response against Omicron subvariants, the Wall Street Journal reports.

Science Papers Present Gene-Edited Mouse Models of Liver Cancer, Hürthle Cell Carcinoma Analysis

In Science this week: a collection of mouse models of primary liver cancer, and more.